International Cannabis Weekly: 446

THE US OFFICIALLY RESCHEDULES CANNABIS, PARTLY…

After years of false starts, political delays and administrative paralysis, the United States federal government has taken its first concrete step toward rescheduling cannabis. Acting Attorney General Todd Blanche signed an order on April 22, moving state-licensed medical cannabis and FDA-approved cannabis drug products from Schedule I to Schedule III of the Controlled Substances Act (CSA).

READ MORE  »

DOES THE UK MEDIA’S CANNABIS COVERAGE REFLECT PUBLIC OPINION?

READ MORE »

SOUTH AFRICA’S CANNABIS INDUSTRY EDGES TOWARDS REGULATED MARKET

READ MORE »

• Medical cannabis has been linked to a major reduction in prescription drug use, data has found.
• Cannabis Industry Council releases global guide for medical cannabis travellers.
• France’s DGAL has reignited the crackdown against CBD products and operators.
• The National Organisation for the Reform of Marijuana Laws has outlined the path forward for cannabis reform in Hungary.
• A French audit court has delivered a verdict on the cannabis fine enforcement system.
• TSRgrow named among top companies driving European cannabis market expansion.

USE ICW15 FOR 15% OFF »

• A new congressional bill is proposing to let state agencies provide cannabis for research.
• A new Minnesota study finds teen cannabis use lower than before legalisation.
• Cresco Labs marks major production milestone with 200,000-pound cannabis harvest.
• American farmers grew $739 million worth of legal hemp last year, new figures show.
• US senators are moving to let states opt out of hemp product ban, new reports reveal.
• A US judge allows Medicare hemp pilot to proceed despite critics escalating opposition.

• Seth Rogen’s cannabis company faces fresh pressure as market challenges mount.
• Mail-order cannabis continues shaping consumer access across Canada’s legal market.
• Tilray has marked 4/20 by reaffirming its cannabis leadership and commitment to advancing medical care.
• Canada has reported record sales for hemp products as consumer demand rises.
• Nextleaf has advanced its capex-light model with new micro-processing site licence.
• Small businesses remain the foundation of Canada’s legal cannabis industry, new figures show.

• Sint Maarten reopens debate over cannabis legalisation and market regulation.
• Medical cannabis use is starting to rise among patients with work-related stress in Brazil.
• The region of Praia da Pipa in Brazil hosts first cannabis education and culture event.
• Argentina is facing renewed calls to restart its national cannabis debate in the Senate.

• Agential Cannabis 2026 takes shape as APAC’s B2B medicinal cannabis marketplace.
• TGA has finalised new safety report that could reshape Australian cannabis market.
• Waikato medicinal cannabis grower opens new extraction facility in New Zealand.
• Little Green Pharma delays Cannatrek shareholder vote as conditions remain outstanding.

• Ghana has opened up its cannabis licences to diaspora as legal industry takes shape.
• Morocco’s legal cannabis production reached 19,576 quintals during 2025, data reveals.